Jong Kil W, Nichols Jr RC, Hoppe BS, Morris CG, Marcus Jr RB, Mendenhall W, et al. Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression. AO [Internet]. 2013 Apr. 1 [cited 2025 Feb. 22];52(3):492-7. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/27724